<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.biomedcentral.com/feeds/latestarticles/journal?journal=bmcpublichealth&amp;quantity=&amp;format=rss&amp;version=">
        <title>BMC Public Health - Latest Articles</title>
        <link>http://www.biomedcentral.com/bmcpublichealth/</link>
        <description>The latest research articles published by BMC Public Health</description>
        <dc:date>2012-06-01T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2458/12/398" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2458/12/397" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2458/12/396" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2458/12/395" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2458/12/394" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2458/12/393" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2458/12/392" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2458/12/391" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2458/12/388" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2458/12/387" />
                            </rdf:Seq>
        </items>
                 <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.biomedcentral.com/1471-2458/12/398">
        <title>Improving the cost-effectiveness of cardiovascular disease prevention in Australia: a modelling study</title>
        <description>Background:
Cardiovascular disease is the leading cause of death worldwide. Like many countries, Australia is currently changing its guidelines for cardiovascular disease prevention from drug treatment for everyone with &apos;high blood pressure&apos; or &apos;high cholesterol&apos;, to prevention based on a patient&apos;s absolute risk. In this research, we model cost-effectiveness of cardiovascular disease prevention with blood pressure and lipid drugs in Australia under three different scenarios: (1) the true current practice in Australia; (2) prevention as intended under the current guidelines; and (3) prevention according to proposed absolute risk levels. We consider the implications of changing to absolute risk-based cardiovascular disease prevention, for the health of the Australian people and for Government health sector expenditure over the long term.
Methods:
We evaluate cost-effectiveness of statins, diuretics, ACE inhibitors, calcium channel blockers and beta-blockers, for Australian men and women, aged 35 to 84 years, who have never experienced a heart disease or stroke event. Epidemiological changes and health care costs are simulated by age and sex in a discrete time Markov model, to determine total impacts on population health and health sector costs over the lifetime, from which we derive cost-effectiveness ratios in 2008 Australian dollars per quality-adjusted life year.
Results:
Cardiovascular disease prevention based on absolute risk is more cost-effective than prevention under the current guidelines based on single risk factor thresholds, and is more cost-effective than the current practice, which does not follow current clinical guidelines. Recommending blood pressure-lowering drugs to everyone with at least 5% absolute risk and statin drugs to everyone with at least 10% absolute risk, can achieve current levels of population health, while saving $5.4 billion for the Australian Government over the lifetime of the population. But savings could be as high as $7.1 billion if Australia could match the cheaper price of statin drugs in New Zealand.
Conclusions:
Changing to absolute risk-based cardiovascular disease prevention is highly recommended for reducing health sector spending, but the Australian Government must also consider measures to reduce the cost of statin drugs, over and above the legislated price cuts of November 2010.</description>
        <link>http://www.biomedcentral.com/1471-2458/12/398</link>
                <dc:creator>Linda Cobiac</dc:creator>
                <dc:creator>Anne Magnus</dc:creator>
                <dc:creator>Jan Barendregt</dc:creator>
                <dc:creator>Rob Carter</dc:creator>
                <dc:creator>Theo Vos</dc:creator>
                <dc:source>BMC Public Health 2012, null:398</dc:source>
        <dc:date>2012-06-01T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2458-12-398</dc:identifier>
                                <prism:require>/content/figures/1471-2458-12-398-toc.gif</prism:require>
                <prism:publicationName>BMC Public Health</prism:publicationName>
        <prism:issn>1471-2458</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>398</prism:startingPage>
        <prism:publicationDate>2012-06-01T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2458/12/397">
        <title>Long-term health-enhancing physical activity in rheumatoid arthritis - the PARA 2010 study</title>
        <description>Background:
People with rheumatoid arthritis (RA) suffer increased risk of disability and premature mortality. Health-enhancing physical activity (HEPA) could be one important factor to reduce this risk. Rising health care costs call for the development and evaluation of new modes of rehabilitation, including physical activity in settings outside the health care system.
Methods:
This cohort study targets 450 patients with RA that do not currently meet HEPA recommendations, recruited from six hospitals reporting to the Swedish Rheumatology Quality Registers (SRQ). We have developed a two-year real-life intervention program including a minimum of twice-weekly circuit training, moderately intense physical activity the remaining days of the week and group meetings to support behavior change every other week. Our hypothesis is that increased physical activity and exercise will improve perceived health, reduce pain and fatigue, increase muscle function and aerobic capacity, impact psychosocial factors and prevent future cardiovascular events. Research questions regard outcomes, retention rates, dose-response matters and the exploration of responder characteristics. This protocol outlines recruitment procedure, design, assessment methods and the intervention program of the study.DiscussionThe PARA 2010 project is designed to expand the knowledge on HEPA in RA by a progressive approach regarding population, setting, intervention, time frames and outcome measures. To our knowledge this is the first long-term HEPA program based on Social Cognitive Theory, and performed in a real life environment to demonstrate if this new setting can promote increased and maintained physical activity in people with RA.Trial registration numberISRCTN25539102</description>
        <link>http://www.biomedcentral.com/1471-2458/12/397</link>
                <dc:creator>Birgitta Nordgren</dc:creator>
                <dc:creator>Cecilia Fridén</dc:creator>
                <dc:creator>Ingrid Demmelmaier</dc:creator>
                <dc:creator>Gunnar Bergström</dc:creator>
                <dc:creator>Christina Opava</dc:creator>
                <dc:source>BMC Public Health 2012, null:397</dc:source>
        <dc:date>2012-06-01T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2458-12-397</dc:identifier>
                                <prism:require>/content/figures/1471-2458-12-397-toc.gif</prism:require>
                <prism:publicationName>BMC Public Health</prism:publicationName>
        <prism:issn>1471-2458</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>397</prism:startingPage>
        <prism:publicationDate>2012-06-01T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2458/12/396">
        <title>Are acceptance rates of a national preventive home visit programme for older people socially imbalanced?: a cross sectional study in Denmark</title>
        <description>Background:
Preventive home visits are offered to community dwelling older people in Denmark aimed at maintaining their functional ability for as long as possible, but only two thirds of older people accept the offer from the municipalities. The purpose of this study is to investigate 1) whether socioeconomic status was associated with acceptance of preventive home visits among older people and 2) whether municipality invitational procedures for the preventive home visits modified the association.
Methods:
The study population included 1,023 community dwelling 80-year-old individuals from the Danish intervention study on preventive home visits. Information on preventive home visit acceptance rates was obtained from questionnaires. Socioeconomic status was measured by financial assets obtained from national registry data, and invitational procedures were identified through the municipalities. Logistic regression analyses were used, adjusted by gender.
Results:
Older persons with high financial assets accepted preventive home visits more frequently than persons with low assets (adjusted OR=1.5 (CI95%: 1.1-2.0)). However, the association was attenuated when adjusted by the invitational procedures. The odds ratio for accepting preventive home visits was larger among persons with low financial assets invited by a letter with a proposed date than among persons with high financial assets invited by other procedures, though these estimates had wide confidence intervals.
Conclusion:
High socioeconomic status was associated with a higher acceptance rate of preventive home visits, but the association was attenuated by invitational procedures. The results indicate that the social inequality in acceptance of publicly offered preventive services might decrease if municipalities adopt more proactive invitational procedures.</description>
        <link>http://www.biomedcentral.com/1471-2458/12/396</link>
                <dc:creator>Yukari Yamada</dc:creator>
                <dc:creator>Anette Ekmann</dc:creator>
                <dc:creator>Charlotte Juul Nilsson</dc:creator>
                <dc:creator>Mikkel Vass</dc:creator>
                <dc:creator>Kirsten Avlund</dc:creator>
                <dc:source>BMC Public Health 2012, null:396</dc:source>
        <dc:date>2012-06-01T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2458-12-396</dc:identifier>
                                <prism:require>/content/figures/1471-2458-12-396-toc.gif</prism:require>
                <prism:publicationName>BMC Public Health</prism:publicationName>
        <prism:issn>1471-2458</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>396</prism:startingPage>
        <prism:publicationDate>2012-06-01T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2458/12/395">
        <title>Long working hours and metabolic syndrome among Japanese men: a cross-sectional study</title>
        <description>Background:
The link between long working hours and health has been extensively studied for decades. Despite global concern regarding metabolic syndrome, however, no studies to date have solely evaluated the relationship between long working hours and that syndrome. We therefore examined the association between long working hours and metabolic syndrome in a cross-sectional study.
Methods:
Between May and October 2009, we collected data from annual health checkups and questionnaires from employees at a manufacturing company in Shizuoka, Japan. Questionnaires were returned by 1,601 workers (response rate: 96.2%; 1,314 men, 287 women). After exclusions, including women because of a lack of overtime work, the analysis was performed for 933 men. We calculated odds ratios (ORs) and 95% confidence intervals (CIs) for metabolic syndrome. Further, we conducted a stratified analysis by age-group (&lt;40 years vs. [greater than or equal to]40 years).
Results:
Metabolic syndrome was identified in 110 workers (11.8%). We observed a positive association between working hours and metabolic syndrome after adjusting for age, occupation, shift work, smoking status, frequency of alcohol consumption, and cohabiting status. Compared with subjects who worked 7-8 h/day, multivariate ORs for metabolic syndrome were 1.66 (95% CI, 0.91-3.01), 1.48 (95% CI, 0.75-2.90), and 2.32 (95% CI, 1.04-5.16) for those working 8-9 h/day, 9-10 h/day, and &gt;10 h/day, respectively. Similar patterns were obtained when we excluded shift workers from the analysis. In age-stratified analysis, the corresponding ORs among workers aged [greater than or equal to]40 years were 2.02 (95% CI, 1.04-3.90), 1.21 (95% CI, 0.53-2.77), and 3.14 (95% CI, 1.24-7.95). In contrast, no clear association was found among workers aged &lt;40 years.
Conclusions:
The present study suggests that 10 h/day may be a trigger level of working hours for increased risk of metabolic syndrome among Japanese male workers.</description>
        <link>http://www.biomedcentral.com/1471-2458/12/395</link>
                <dc:creator>Tomoko Kobayashi</dc:creator>
                <dc:creator>Etsuji Suzuki</dc:creator>
                <dc:creator>Soshi Takao</dc:creator>
                <dc:creator>Hiroyuki Doi</dc:creator>
                <dc:source>BMC Public Health 2012, null:395</dc:source>
        <dc:date>2012-05-31T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2458-12-395</dc:identifier>
                                <prism:require>/content/figures/1471-2458-12-395-toc.gif</prism:require>
                <prism:publicationName>BMC Public Health</prism:publicationName>
        <prism:issn>1471-2458</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>395</prism:startingPage>
        <prism:publicationDate>2012-05-31T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2458/12/394">
        <title>Oral versus intramuscular administration of vitamin B12 for the treatment of patients with vitamin B12 deficiency: a pragmatic, randomised, multicentre, non-inferiority clinical trial undertaken in the primary healthcare setting (Project OB12)</title>
        <description>Background:
The oral administration of vitamin B12 offers a potentially simpler and cheaper alternative to parenteral administration, but its effectiveness has not been definitively demonstrated. The following protocol was designed to compare the effectiveness of orally and intramuscularly administered vitamin B12 in the treatment of patients [greater than or equal to]65 years of age with vitamin B12 deficiency.
Methods:
The proposed study involves a controlled, randomised, multicentre, parallel, non-inferiority clinical trial lasting one year, involving 23 primary healthcare centres in the Madrid region (Spain), and patients [greater than or equal to]65 years of age. The minimum number of patients required for the study was calculated as 320 (160 in each arm). Bearing in mind an estimated 8-10% prevalence of vitamin B12 deficiency among the population of this age group, an initial sample of 3556 patients will need to be recruited.Eligible patients will be randomly assigned to one of the two treatment arms. In the intramuscular treatment arm, vitamin B12 will be administered as follows: 1 mg on alternate days in weeks 1 and 2, 1 mg/week in weeks 3-8, and 1 mg/month in weeks 9-52. In the oral arm, the vitamin will be administered as: 1 mg/day in weeks 1-8 and 1 mg/week in weeks 9-52. The main outcome variable to be monitored in both treatment arms is the normalisation of the serum vitamin B12 concentration at weeks 8, 26 and 52; the secondary outcome variables include the serum concentration of vitamin B12 (in pg/ml), adherence to treatment, quality of life (EuroQoL-5D questionnaire), patient satisfaction and patient preferences. All statistical tests will be performed with intention to treat and per protocol. Logistic regression with random effects will be used to adjust for prognostic factors. Confounding factors or factors that might alter the effect recorded will be taken into account in analyses.DiscussionThe results of this study should help establish, taking quality of life into account, whether the oral administration of vitamin B12 is an effective alternative to its intramuscular administration. If this administration route is effective, it should provide a cheaper means of treating vitamin B12 deficiency while inducing fewer adverse effects. Having such an alternative would also allow patient preferences to be taken into consideration at the time of prescribing treatment.Trial registrationThis trial has been registered with ClinicalTrials.gov, number NCT 01476007, and under EUDRACT number 2010-024129-20.</description>
        <link>http://www.biomedcentral.com/1471-2458/12/394</link>
                <dc:creator>Teresa Sanz-Cuesta</dc:creator>
                <dc:creator>Paloma González-Escobar</dc:creator>
                <dc:creator>Rosario Riesgo-Fuertes</dc:creator>
                <dc:creator>Sofía Garrido-Elustondo</dc:creator>
                <dc:creator>Isabel del Cura-González</dc:creator>
                <dc:creator>Jesús Martín-Fernández</dc:creator>
                <dc:creator>Esperanza Escortell-Mayor</dc:creator>
                <dc:creator>Francisco Rodríguez-Salvanés</dc:creator>
                <dc:creator>Marta García-Solano</dc:creator>
                <dc:creator>Rocío González-González</dc:creator>
                <dc:creator>María Ángeles Martín-de la Sierra-San Agustín</dc:creator>
                <dc:creator>Carmen Olmedo-Lucerón</dc:creator>
                <dc:creator>María Luisa Sevillano Palmero</dc:creator>
                <dc:creator>Carmen Mateo-Ruiz</dc:creator>
                <dc:creator>Beatriz Medina-Bustillo</dc:creator>
                <dc:creator>Antonio Valdivia-Pérez</dc:creator>
                <dc:creator>Francisca García-de Blas-González</dc:creator>
                <dc:creator>José Enrique Mariño-Suárez</dc:creator>
                <dc:creator>Ricardo Rodríguez-Barrientos</dc:creator>
                <dc:creator>Gloria Ariza-Cardiel</dc:creator>
                <dc:creator>Luisa María Cabello-Ballesteros</dc:creator>
                <dc:creator>Elena Polentinos-Castro</dc:creator>
                <dc:creator>Milagros Rico-Blázquez</dc:creator>
                <dc:creator>Ma Teresa Rodríguez-Monje</dc:creator>
                <dc:creator>Sonia Soto-Díaz</dc:creator>
                <dc:creator>Susana Martín-Iglesias</dc:creator>
                <dc:creator>Ramón Rodríguez-González</dc:creator>
                <dc:creator>Irene Bretón-Lesmes</dc:creator>
                <dc:creator>María Vicente-Herrero</dc:creator>
                <dc:creator>Jesús Sánchez-Díaz</dc:creator>
                <dc:creator>Tomás Gómez-Gascón</dc:creator>
                <dc:creator>Mercedes Drake-Canela</dc:creator>
                <dc:creator>Ángel Asúnsolo-del Barco</dc:creator>
                <dc:creator>OB12 Group</dc:creator>
                <dc:source>BMC Public Health 2012, null:394</dc:source>
        <dc:date>2012-05-31T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2458-12-394</dc:identifier>
                                <prism:require>/content/figures/1471-2458-12-394-toc.gif</prism:require>
                <prism:publicationName>BMC Public Health</prism:publicationName>
        <prism:issn>1471-2458</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>394</prism:startingPage>
        <prism:publicationDate>2012-05-31T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2458/12/393">
        <title>&apos;Decision support system (DSS) for prevention of cardiovascular disease (CVD) among hypertensive (HTN) patients in Andhra Pradesh, India&apos; - a
cluster randomised community intervention trial</title>
        <description>Background:
Very few studies having decision support systems as an intervention report on patient outcomes for cardiovascular disease in the Western world. The potential role of decision support system for themanagement of blood pressure among Indian hypertensives remains unclear. We propose a cluster randomised trial that aims to test the effectiveness and cost effectiveness of DSS among Indian hypertensive patients.
Methods:
The trail design is a cluster randomised community intervention trial, in which the participants would be adult male and female hypertensive patients, in the age group of 35 to 64 years, reporting to the Primary Health Care centres of Mahabubnagar district, Andhra Pradesh, India. The objective of the study is to test the effectiveness and compare the cost effectiveness and cost utility among hypertensive subjects randomized to receive either decision support system or a chart based algorithmic support system in urban and rural areas of a district in the state of Andhra Pradesh, India (baseline versus 12 months follow up). The primary outcome would be a comparison of the systolic blood pressure at 0 and 12 months among hypertensive patients randomized to receive the decision support system or the chart based algorithmic support system. Computer generated randomisation and an investigator and analyser blinded method would be followed. 1600 participants; 800 to each arm; each arm having eight clusters of hundred participants each have been recruited between 01 August 2011 - 01 March 2012. A twelve month follow up will be completed by March 2013 and results are expected by April 2013.DiscussionThis cluster randomized community intervention trial on DSS will enable policy makers to find out the effectiveness, cost effectiveness and cost utility of decision support system for management of blood pressure among hypertensive patients in India. Most of the previous studies on decision support system have focused on physician performance, adherence and on preventive care reminders. The uniqueness of the proposed study lies in finding out the effectiveness of a decision support system on patient relatedoutcomes.Trial Registration: CTRI/2012/03/002476, Clinical Trial Registry - India.</description>
        <link>http://www.biomedcentral.com/1471-2458/12/393</link>
                <dc:creator>Raghupathy Anchala</dc:creator>
                <dc:creator>Hira Pant</dc:creator>
                <dc:creator>Dorairaj Prabhakaran</dc:creator>
                <dc:creator>Oscar Franco</dc:creator>
                <dc:source>BMC Public Health 2012, null:393</dc:source>
        <dc:date>2012-05-31T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2458-12-393</dc:identifier>
                                <prism:require>/content/figures/1471-2458-12-393-toc.gif</prism:require>
                <prism:publicationName>BMC Public Health</prism:publicationName>
        <prism:issn>1471-2458</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>393</prism:startingPage>
        <prism:publicationDate>2012-05-31T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2458/12/392">
        <title>Women show a closer association between educational level and hypertension or diabetes mellitus than males: a secondary analysis from the Austrian HIS</title>
        <description>Background:
Lifestyle diseases and cardiovascular complications are dramatically increasing, but little is known about the impact of educational level and health behaviour in men and women in different populations. Therefore, we aimed to investigate the association between educational level (EL) and self-reported chronic diseases and health behaviour in both sexes.
Methods:
Data were derived from the Austrian Health Interview Surveys 2006/2007, which includes 13 558 persons (50.9% females). The associations between EL and the risk of obesity, hypertension, diabetes, myocardial infarction, stroke and anxiety disorders or depression, nutrition, exercise, and smoking were evaluated. University education served as the reference category (EL4), the lowest educational level was required schooling only (EL0).
Results:
Only among women did the risk for diabetes mellitus and hypertension increase with decreasing educational level with the highest rates for EL0 OR [95% CI] adjusted for age, income, family status and lifestyle: 3.7 [1.7-8.0], and 2.5 [1.8-3.5], respectively. Only among the men, however, did the risk for stroke increase with decreasing educational level adjusted OR for EL0: 8.5 [1.7-42.7]. For anthropometric measures and lifestyle factors in both sexes the risk increased with decreasing EL.
Conclusion:
EL affects lifestyle, overweight and obesity in both sexes. The apparent sex-specific differences in the association between the prevalence of some chronic disease with EL call for further investigation.</description>
        <link>http://www.biomedcentral.com/1471-2458/12/392</link>
                <dc:creator>Alexandra Kautzky-Willer</dc:creator>
                <dc:creator>Thomas Dorner</dc:creator>
                <dc:creator>Ann Jensby</dc:creator>
                <dc:creator>Anita Rieder</dc:creator>
                <dc:source>BMC Public Health 2012, null:392</dc:source>
        <dc:date>2012-05-30T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2458-12-392</dc:identifier>
                                <prism:require>/content/figures/1471-2458-12-392-toc.gif</prism:require>
                <prism:publicationName>BMC Public Health</prism:publicationName>
        <prism:issn>1471-2458</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>392</prism:startingPage>
        <prism:publicationDate>2012-05-30T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2458/12/391">
        <title>Lessons drawn from research utilization in the maternal iodine supplementation policy development in Thailand.</title>
        <description>In this paper, the authors share their experience on evidence utilization in the development of Thailand&apos;s maternal iodine supplementation policy in 2009-2010. Observations and reflections on their experience  of engaging with research for policymaking are illustrated. The case study indicates that rapid approaches in conducting research, namely a targeted literature review and cross-sectional survey of professionals&apos; opinions and current practices were efficient in achieving the timeliness of evidence provision. In addition pro-activity, trust and interaction between researchers and policymakers enhanced the research-policy integration. The Thai experience may be useful for other developing countries which pursue evidence-informed policymaking, despite differences in the health system context.</description>
        <link>http://www.biomedcentral.com/1471-2458/12/391</link>
                <dc:creator>Utsana Tonmukayakul</dc:creator>
                <dc:creator>Roman Perez Velasco</dc:creator>
                <dc:creator>Sripen Tantivess</dc:creator>
                <dc:creator>Yot Teerawattananon</dc:creator>
                <dc:source>BMC Public Health 2012, null:391</dc:source>
        <dc:date>2012-05-30T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2458-12-391</dc:identifier>
                                <prism:require>/content/figures/1471-2458-12-391-toc.gif</prism:require>
                <prism:publicationName>BMC Public Health</prism:publicationName>
        <prism:issn>1471-2458</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>391</prism:startingPage>
        <prism:publicationDate>2012-05-30T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2458/12/388">
        <title>Increasing blood pressure and its associated factors in Canadian children and adolescents from Canadian Health Measures Survey</title>
        <description>Background:
Canada is facing a childhood obesity epidemic. Elevated blood pressure (BP) is a major complication of obesity. Reports on the impact of excess adiposity on BP in children and adolescents have varied significantly across studies. We evaluated the independent effects of obesity, physical activity, family history of hypertension, and socioeconomic status on BP in a nationally representative sample of children and adolescents.
Methods:
We analysed cross-sectional data for 1850 children aged 6 to 17 years who participated in the Canadian Health Measures Survey, Cycle 1, 2007-2009. Systolic BP (SBP) and diastolic BP (DBP) were age-, sex-, and height-adjusted to z-scores (SBPZ and DBPZ). Body mass index (BMI) z-scores were calculated based on World Health Organization growth standards. Multivariate linear regression was used to evaluate the independent effects of relevant variables on SBPZ and DBPZ.
Results:
For most age/sex groups, obesity was positively associated with SBP. Being obese was associated with higher DBP in adolescent boys only. The BP effect of obesity showed earlier in young girls than boys. Obese adolescents were estimated to have an average 7.6 mmHg higher SBP than normal weight adolescents. BMI had the strongest effect on BP among obese children and adolescents. Moderately active adolescent boys had higher SBP (3.9 mmHg) and DBP (4.9 mmHg) than physically active boys. Family history of hypertension showed effects on SBP and DBP in younger girls and adolescent boys. Both family income and parent education demonstrated independent associations with BP in young children.
Conclusions:
Our findings demonstrate the early impact of excess adiposity, insufficient physical activity, family history of hypertension, and socioeconomic inequalities on BP. Early interventions to reduce childhood obesity can, among other things, reduce exposure to prolonged BP elevation and the future risk of cardiovascular disease.</description>
        <link>http://www.biomedcentral.com/1471-2458/12/388</link>
                <dc:creator>Yipu Shi</dc:creator>
                <dc:creator>Margaret de Groh</dc:creator>
                <dc:creator>Howard Morrison</dc:creator>
                <dc:source>BMC Public Health 2012, null:388</dc:source>
        <dc:date>2012-05-29T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2458-12-388</dc:identifier>
                                <prism:require>/content/figures/1471-2458-12-388-toc.gif</prism:require>
                <prism:publicationName>BMC Public Health</prism:publicationName>
        <prism:issn>1471-2458</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>388</prism:startingPage>
        <prism:publicationDate>2012-05-29T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2458/12/387">
        <title>Diet, occupational exposure and early asthma incidence among bakers, pastry makers and hairdressers</title>
        <description>Background:
The natural history of occupational asthma (OA) is influenced by many determinants. This study aims to assess the combined roles of personal characteristics, including occupational exposure and nutritional habits, on the incidence of OA during the first years at work.
Methods:
A nested case-control study was conducted within a retrospective cohort of young workers in the bakery, pastry-making and hairdressing sectors. Cases were subjects diagnosed as &apos;confirmed&apos; or &apos;probable&apos; OA consecutively to a medical visit (N=31). Controls were subjects without OA (N=196). Atopy was defined after blood specific IgE analysis, based on the PhadiatopTM test. Occupational exposure was characterized by standardized questionnaires and diet patterns by a food frequency questionnaire.
Results:
Among bakers and pastry-makers, only atopy is an independent risk factor of OA (OR=10.07 95%CI [2.76 - 36.65]). Among hairdressers, several variables are associated with OA. Body mass index (unit OR=1.24 [1.03 - 1.48]) and the score of exposure intensity (unit OR=1.79 [1.05 - 3.05]) are independent predictors of OA, but the role of atopy is weak (OR=4.94 [0.66 - 36.75]). Intake of vitamin A is higher among hairdressers cases (crude p=0.002, adjusted p=0.01 after control for body mass index and atopy); the same observation is made for vitamin D (crude p=0.004, adjusted p=0.01).
Conclusion:
This study suggests that the influence of several factors on the incidence of OA, including dietary vitamins, might vary across exposure settings.</description>
        <link>http://www.biomedcentral.com/1471-2458/12/387</link>
                <dc:creator>Thomas Rémen</dc:creator>
                <dc:creator>Dovi-Stéphanie Acouetey</dc:creator>
                <dc:creator>Christophe Paris</dc:creator>
                <dc:creator>Denis Zmirou-Navier</dc:creator>
                <dc:source>BMC Public Health 2012, null:387</dc:source>
        <dc:date>2012-05-29T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2458-12-387</dc:identifier>
                                <prism:require>/content/figures/1471-2458-12-387-toc.gif</prism:require>
                <prism:publicationName>BMC Public Health</prism:publicationName>
        <prism:issn>1471-2458</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>387</prism:startingPage>
        <prism:publicationDate>2012-05-29T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>

